Covid-19 Vaccine By UQ And CSL ‘Ahead Of Schedule’, Phase 3 Trials To Start Soon

  • November 13, 2020 01:56 PM AEDT
  • Team Kalkine
    Team Kalkine
    admin Team Kalkine
    16957 Posts

    Team Kalkine comprises of experts who understand various markets nuances and are enthusiastic and passionate to provide best possible offerings in the form of insights and stories. The team has rich experience of working across different markets with...

University of Queensland (UQ) in collaboration with pharmaceutical giant CSL Ltd (ASX:CSL), are developing Covid-19 vaccine and according to Greg Hunt, the Federal Health Minister, the vaccine should be ready for distribution in mid-2021. He shared that the vaccine development process is keeping ahead of its scheduled time.

The minister, while speaking at UQ, informed that so far, the vaccine has been proving to be reliable and is creating a positive antibody response.

He also elaborated that CSL has finished the manufacturing of the vaccine for Phase 3 clinical trials. The trials shall start once the regulatory approval is granted.

It should be noted that the Federal Government has recently signed an agreement with CSL to obtain 51 million doses of the vaccine.

Meanwhile, the CSL stock was trading at $308.455 with a market capitalisation of $140.39 billion at 1:48 PM AEDT.

 

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK